Written answers

Tuesday, 9 May 2023

Department of Health

Medicinal Products

Photo of Cian O'CallaghanCian O'Callaghan (Dublin Bay North, Social Democrats)
Link to this: Individually | In context | Oireachtas source

663. To ask the Minister for Health the reasons for the ongoing shortages of the medication concerta; the action he will take to ensure the regular supply of the medication is restored; and if he will make a statement on the matter. [21773/23]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

Janssen, the company that places the Concerta XL products on the market, has advised that it is encountering global supply chain issues related to component availability and increased demand in multiple markets.

Supplies of Concerta XL are currently available on the Irish market. However, Janssen has stated that it is managing the supply of existing stock to ensure equitable distribution to mitigate the impact on patients in Ireland and that it is working closely with pharmacies to ensure patients receive their medication.

The company has advised that if there are any localised supply issues, pharmacies can contact Janssen medical information, on 1800709122, to release the required quantity for the patient.

Janssen has requested that orders are limited to the amount of Concerta XL needed in a given month as the company attempts to build stock levels back up. Ordering more than necessary could increase pressure on the supply levels at a national level and inadvertently impact on other patients.

Comments

No comments

Log in or join to post a public comment.